Patent application number | Description | Published |
20100130455 | BISMETHYLENE-17A CARBOLACTONES AND RELATED USES - Described herein are bismethylene-17α carbolactone derivatives having progestational and/or antimineralocorticoid and/or aldosterone antagonistic activity. Also described herein are methods of preparing and using these novel compounds. | 05-27-2010 |
20100137264 | PROGESTATIONAL 3-(6,6-ETHYLENE-17B-HYDROXY-3-OXO-17A-PREGNA-4-ENE-17A-YL)PROPIONIC ACID G-LACTONES - Described herein are 3-(6,6-ethylene-17β-hydroxy-3-oxo-17α-pregna-4-ene-17α-yl)propionic acid γ-lactone derivatives having progestational and aldosterone antagonistic activity. Also described herein are methods of preparing and using these novel compounds. | 06-03-2010 |
20100261896 | METHODS FOR THE PREPARATION OF DROSPIRENONE - Described herein are methods of making drospirenone. Also described are intermediate compounds that may be used to synthesis drospirenone. | 10-14-2010 |
20100273759 | PROGESTERONE ANTAGONISTS - Described herein are compounds which exhibit progesterone antagonistic effects and methods of treating cancer using such compounds. | 10-28-2010 |
20110236462 | INTRAVAGINAL DRUG DELIVERY DEVICE - Described herein is an intravaginal drug delivery system. In an embodiment the intravaginal drug delivery system includes a progestin and estrogen compound, and releases the active ingredients in a fixed physiological ratio over a prolonged period of time to produce a contraceptive state in a female. | 09-29-2011 |
20110250274 | ESTRIOL FORMULATIONS - Disclosed herein are oral dosage forms and methods of their use, in particular oral dosage systems for the delivery of estriol compounds. Embodiments described herein relate to rapidly disintegrating oral dosage formulations that disintegrate in the saliva of the buccal and/or sublingual and/or esophageal cavity. Oral dosage forms described herein relate to stabilized amorphous and nanocrystalline forms of the active ingredients of the formulations. | 10-13-2011 |
20130029953 | PROGESTERONE ANTAGONISTS - Described herein are compounds which either act as pure antiprogestins or as antiprogestins with partial agonistic activity and methods of treating cancer using such compounds. | 01-31-2013 |
20130123523 | METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL - Described herein is a process for the synthesis of etonogestrel and desogestrel and intermediates used to form etonogestrel and desogestrel. | 05-16-2013 |
20140364600 | IMIDAZOLYL PROGESTERONE ANTAGONISTS - Described herein are imidazolyl compounds which either act as pure antiprogestins and methods of using such pure antagonists for gynecological indications and breast cancer. | 12-11-2014 |
20150018322 | PRO-DRUG FORMING COMPOUNDS - Various prodrug compounds having the general structure: Active agent-(acid)-(linker)-SO | 01-15-2015 |